Microangiopathic hemolytic anemia surgery: Difference between revisions
Jump to navigation
Jump to search
Created page with "__NOTOC__ {{Microangiopathic hemolytic anemia}} Please help WikiDoc by adding content here. It's easy! Click here to learn about editing. ==R..." |
MydahSajid (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Microangiopathic hemolytic anemia}} | {{Microangiopathic hemolytic anemia}} {{AE}} {{MSJ}} | ||
* Surgery is not the first-line treatment option for [[patient]]s with [[microangiopathic hemolytic anemia]]. [[Splenectomy]] is usually reserved for [[patient]]s with recurrent [[thrombotic thrombocytopenic purpura]]<ref name="pmid20858382">{{cite journal| author=Dubois L, Gray DK| title=Case series: splenectomy: does it still play a role in the management of thrombotic thrombocytopenic purpura? | journal=Can J Surg | year= 2010 | volume= 53 | issue= 5 | pages= 349-55 | pmid=20858382 | doi= | pmc=2947115 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20858382 }} </ref>. It has shown to reduce [[relapse]] rate in these [[patient]]s. | |||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Latest revision as of 14:50, 30 January 2021
|
Microangiopathic hemolytic anemia Microchapters |
|
Differentiating Microangiopathic hemolytic anemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Microangiopathic hemolytic anemia surgery On the Web |
|
American Roentgen Ray Society Images of Microangiopathic hemolytic anemia surgery |
|
Directions to Hospitals Treating Microangiopathic hemolytic anemia |
|
Risk calculators and risk factors for Microangiopathic hemolytic anemia surgery |
Associate Editor(s)-in-Chief: Mydah Sajid, MD[1]
- Surgery is not the first-line treatment option for patients with microangiopathic hemolytic anemia. Splenectomy is usually reserved for patients with recurrent thrombotic thrombocytopenic purpura[1]. It has shown to reduce relapse rate in these patients.